Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity

被引：31
|
作者：
Qu, Menghua [1 ]
Liu, Zhihao [1 ]
Zhao, Dan [1 ]
Wang, Changyuan [1 ]
Zhang, Jianbin [1 ]
Tang, Zeyao [1 ]
Liu, Kexin [1 ]
Shu, Xiaohong [1 ]
Yuan, Hong [2 ]
Ma, Xiaodong [1 ]
机构：
[1] Dalian Med Univ, Coll Pharm, Dalian 116044, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Clin Lab, Dalian 116011, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2017年 / 25卷 / 15期
基金：
中国国家自然科学基金;
关键词：
Cancer; FAK; Inhibitor; Pyrimidine; Sulfonamide; IN-VIVO; CANCER; DISCOVERY; CELLS; ASSAY;
D O I：
10.1016/j.bmc.2017.05.044
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A class of sulfonamide-substituted diphenylpyrimidines (Sul-DPPYs) were synthesized to improve activity against the focal adhesion kinase (FAK). Most of these new Sul-DPPYs displayed moderate activity against the FAK enzyme with IC50 values of less than 100 nM; regardless, they could effectively inhibit several classes of refractory cancer cell lines with IC50 values of less than 10 mu M, including the pancreatic cancer cell lines (AsPC-1, Panc-1 and BxPC-3), the NSCLC-resistant H1975 cell line, and the B lymphocyte cell line (Ramos cells). Results of flow cytometry indicated that inhibitor 7e promoted apoptosis of pancreatic cancer cells in a dose-dependent manner. In addition, it almost completely induced the apoptosis at a concentration of 10 mu M. Compound 7e may be selected as a potent FAK inhibitor for the treatment of pancreatic cancer. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3989 / 3996
页数：8
相关论文
共 50 条
  • [21] Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors
    Ji, Changjin
    Wang, Shengzheng
    Chen, Shuqiang
    He, Shipeng
    Jiang, Yan
    Miao, Zhenyuan
    Li, Jian
    Sheng, Chunquan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5268 - 5277
  • [22] Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity
    Bolognese, A
    Correale, G
    Manfra, M
    Lavecchia, A
    Mazzoni, O
    Novellino, E
    La Colla, P
    Sanna, G
    Loddo, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) : 849 - 858
  • [23] Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors
    Abu Rabah, Reinad R.
    Sebastian, Anusha
    Vunnam, Srinivasulu
    Sultan, Shaista
    Tarazi, Hamadeh
    Anbar, Hanan S.
    Shehata, Mahmoud K.
    Zaraei, Seyed-Omar
    Elgendy, Sara M.
    Al Shamma, Salma A.
    Omar, Hany A.
    Al-Tel, Taleb H.
    El-Gamal, Mohammed, I
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 69
  • [24] Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors
    Dayde-Cazals, Benedicte
    Fauvel, Benedicte
    Singer, Mathilde
    Feneyrolles, Clemence
    Bestgen, Benoit
    Gassiot, Fanny
    Spenlinhauer, Aurelia
    Warnault, Pierre
    Van Hijfte, Nathalie
    Borjini, Nozha
    Cheve, Gwenael
    Yasri, Abdelaziz
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 3886 - 3905
  • [25] Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors
    Xiao-bing Chen
    Hai-ying Zhu
    Kun Bao
    Li Jiang
    Hong Zhu
    Mei-dan Ying
    Qiao-jun He
    Bo Yang
    Rong Sheng
    Ji Cao
    Acta Pharmacologica Sinica, 2021, 42 : 1160 - 1170
  • [26] Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors
    Chen, Xiao-bing
    Zhu, Hai-ying
    Bao, Kun
    Jiang, Li
    Zhu, Hong
    Ying, Mei-dan
    He, Qiao-jun
    Yang, Bo
    Sheng, Rong
    Cao, Ji
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (07) : 1160 - 1170
  • [27] Design, Synthesis, Biological Evaluation, and Molecular Docking of 2,4-Diaminopyrimidine Derivatives Targeting Focal Adhesion Kinase as Tumor Radiotracers
    Qi, Yueheng
    Li, Ye
    Fang, Yu
    Gao, Hang
    Qiang, Bingchao
    Wang, Shuxia
    Zhang, Huabei
    MOLECULAR PHARMACEUTICS, 2021, 18 (04) : 1634 - 1642
  • [28] Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
    Liu, Yang
    Kong, Li-Jun
    Li, Na
    Liu, Yun-He
    Jia, Mei-Qi
    Liu, Qiu-Ge
    Zhang, Sai-Yang
    Song, Jian
    BIOORGANIC CHEMISTRY, 2023, 141
  • [29] Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia
    Feng, Ziying
    Chen, Aiping
    Shi, Jing
    Zhou, Daoguang
    Shi, Wei
    Qiu, Qianqian
    Liu, Xinhong
    Huang, Wenlong
    Li, Jieming
    Qian, Hai
    Zhang, Wenjie
    BIOORGANIC CHEMISTRY, 2021, 111
  • [30] New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation
    Liang, Liyun
    Wang, Haiwen
    Du, Yongliang
    Luo, Bingling
    Meng, Ning
    Cen, Meifeng
    Huang, Peng
    Ganesan, A.
    Wen, Shijun
    BIOORGANIC CHEMISTRY, 2020, 99
12345